Mitchell Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-18,398
Closed -$2.87M 162
2021
Q2
$2.87M Buy
18,398
+1,171
+7% +$190K 0.63% 60
2021
Q1
$2.68M Buy
17,227
+1,378
+9% +$213K 0.65% 57
2020
Q4
$2.37M Buy
15,849
+1,041
+7% +$147K 0.6% 61
2020
Q3
$1.96M Buy
14,808
+269
+2% +$35.1K 0.57% 59
2020
Q2
$1.69M Buy
14,539
+244
+2% +$28.1K 0.54% 60
2020
Q1
$1.4M Sell
14,295
-3,592
-20% -$471K 0.55% 62
2019
Q4
$2.6M Buy
17,887
+793
+5% +$109K 0.83% 40
2019
Q3
$2.28M Buy
17,094
+903
+6% +$117K 0.77% 41
2019
Q2
$1.85M Buy
16,191
+3,205
+25% +$375K 0.62% 54
2019
Q1
$1.61M Buy
12,986
+2,804
+28% +$319K 0.57% 50
2018
Q4
$1.02M Sell
10,182
-318
-3% -$35.8K 0.43% 57
2018
Q3
$1.34M Buy
10,500
+3,305
+46% +$393K 0.44% 55
2018
Q2
$778K Buy
7,195
+1,864
+35% +$203K 0.28% 64
2018
Q1
$564K Buy
+5,331
New +$619K 0.2% 65

Other funds holding ZBH

Mitchell Capital Management's ZBH Position: Q3 2021 in Review

Mitchell Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 18,398 shares — an estimated $2.87M sold.

Mitchell Capital Management first reported a position in ZBH in Q1 2018 and held it in 14 quarters. The position peaked at $2.87M in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

  • Mitchell Capital Management reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
  • Mitchell Capital Management sold 18,398 Zimmer Biomet shares in Q3 2021, an estimated $2.87M.
  • Mitchell Capital Management first reported a position in Zimmer Biomet in Q1 2018 and held it in 14 quarters.
  • Mitchell Capital Management's Zimmer Biomet position peaked at $2.87M in Q2 2021.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Mitchell Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.